Evusheld long-acting antibody combination approved in the EU for the treatment of COVID-19
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
Evusheld significantly reduced risk of severe COVID-19 or death in TACKLE Phase III treatment trial
Expanding precision medicine, ARTIS icono is designed to enable a wide procedure mix in a single interventional suite
Despite the technological advancements, there remains no alternative to blood and one unit of blood can save as many as three lives
The #pledgemyeyes initiative reached out to over 30 million people across the country and the website registered 3X more pledges compared to the present numbers
The policy aspires to reduce cost of logistics in India to be comparable to global benchmarks by 2030
These moves are designed to strengthen the company’s medical and scientific focus and support its continued record growth through closer alignment of all aspects of strategy, sales, and delivery to delight customers
The event is supported by the Ministry of Commerce & Industry, Government of India and CDSCO, Ministry of Health.
The objective of this study is to evaluate the efficacy of ASC22 (Envafolimab) combined with Chidamide on the viral reservoirs of latently infected cells in HIV patients.
Subscribe To Our Newsletter & Stay Updated